133 related articles for article (PubMed ID: 20299857)
1. Brazilian version of the Addenbrooke Cognitive Examination-revised in the diagnosis of mild Alzheimer disease.
Carvalho VA; Barbosa MT; Caramelli P
Cogn Behav Neurol; 2010 Mar; 23(1):8-13. PubMed ID: 20299857
[TBL] [Abstract][Full Text] [Related]
2. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
[TBL] [Abstract][Full Text] [Related]
3. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
4. [Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia].
Sarasola D; de Luján-Calcagno M; Sabe L; Crivelli L; Torralva T; Roca M; García-Caballero A; Manes F
Rev Neurol; 2005 Dec 16-31; 41(12):717-21. PubMed ID: 16355355
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Spanish Version of the Addenbrooke's Cognitive Examination-Revised (ACE-R).
Torralva T; Roca M; Gleichgerrcht E; Bonifacio A; Raimondi C; Manes F
Neurologia; 2011; 26(6):351-6. PubMed ID: 21232827
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Addenbrooke's cognitive examination for detecting early Alzheimer's disease and mild vascular dementia in a German population.
Alexopoulos P; Greim B; Nadler K; Martens U; Krecklow B; Domes G; Herpertz S; Kurz A
Dement Geriatr Cogn Disord; 2006; 22(5-6):385-91. PubMed ID: 16960447
[TBL] [Abstract][Full Text] [Related]
7. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
[TBL] [Abstract][Full Text] [Related]
9. [Validation of a short test (3MS-R) for detecting Alzheimer's disease].
Alexopoulos P; Nadler K; Cramer B; Herpertz SC; Kurz A
Fortschr Neurol Psychiatr; 2007 Dec; 75(12):728-36. PubMed ID: 17607642
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Spanish version of the Addenbrooke's Cognitive Examination in a rural community in Spain.
García-Caballero A; García-Lado I; González-Hermida J; Recimil M; Area R; Manes F; Lamas S; Berrios G
Int J Geriatr Psychiatry; 2006 Mar; 21(3):239-45. PubMed ID: 16477583
[TBL] [Abstract][Full Text] [Related]
11. Use of an Italian version of the telephone interview for cognitive status in Alzheimer's disease.
Dal Forno G; Chiovenda P; Bressi F; Ferreri F; Grossi E; Brandt J; Rossini PM; Pasqualetti P
Int J Geriatr Psychiatry; 2006 Feb; 21(2):126-33. PubMed ID: 16416467
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
[TBL] [Abstract][Full Text] [Related]
13. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
Matsuda A; Kazui H; Hirono N; Mori E
No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Danish Addenbrooke's Cognitive Examination as a screening test in a memory clinic.
Stokholm J; Vogel A; Johannsen P; Waldemar G
Dement Geriatr Cogn Disord; 2009; 27(4):361-5. PubMed ID: 19299896
[TBL] [Abstract][Full Text] [Related]
15. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
[TBL] [Abstract][Full Text] [Related]
16. Annual conversion to alzheimer disease among patients with memory complaints attending an outpatient memory clinic: the influence of amnestic mild cognitive impairment and the predictive value of neuropsychological testing.
Lehrner J; Gufler R; Guttmann G; Maly J; Gleiss A; Auff E; Dal-Bianco P
Wien Klin Wochenschr; 2005 Sep; 117(18):629-35. PubMed ID: 16416345
[TBL] [Abstract][Full Text] [Related]
17. Category fluency as a screening test for Alzheimer disease in illiterate and literate patients.
Caramelli P; Carthery-Goulart MT; Porto CS; Charchat-Fichman H; Nitrini R
Alzheimer Dis Assoc Disord; 2007; 21(1):65-7. PubMed ID: 17334275
[TBL] [Abstract][Full Text] [Related]
18. Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria.
Visser PJ; Verhey FR
Psychol Med; 2008 Jan; 38(1):113-22. PubMed ID: 17451628
[TBL] [Abstract][Full Text] [Related]
19. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
20. Normative data for healthy middle-aged and elderly performance on the Addenbrooke Cognitive Examination-Revised.
Amaral-Carvalho V; Caramelli P
Cogn Behav Neurol; 2012 Jun; 25(2):72-6. PubMed ID: 22596112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
